GRN1005

· Angiochem Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GRN1005, covering 2015-12-14 to 2016-07-13. Get the full timeline:

Most recent: Clinical Trial Update: GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases [Phase 2]